Le Lézard
Classified in: Health
Subjects: RCL, CFG

Advisory - Several store-brand pain or sinus relief tablets recalled because consumers may be unable to access important safety information


OTTAWA, Nov. 7, 2018 /CNW/ -

Care+ brand Extra Strength Muscle & Back Pain Relief (torn outer label) (CNW Group/Health Canada)

Issue
Vita Health Products is voluntarily recalling several store-brand (Care+, Exact, Life, and Pharmasave) over-the-counter drugs used for pain or sinus relief because of a labelling issue. Consumers may be unable to peel open the wrap-around label on the bottle to access the warning statements, or the label may not peel off completely, which may make it difficult to read some of the important safety information.

This issue is the result of a label manufacturing defect affecting some bottles and does not affect the safety or effectiveness of the product in the bottles. The labelling defect means that some consumers may not be able to access important safety information, such as warnings and instructions for product storage.

Vita Health Products has advised Health Canada that only the products listed below are affected by this issue. The products were distributed at major drug and grocery retail chains across Canada.

Who is affected

Affected products

 

Description


DIN

Lot

Expiry

Units Distributed

Care+ brand

Extra Strength Muscle & Back

Pain Relief

40 count package

02239141

7L3044GZZ

JL/2020

2,973

02239141

8E2054L0W

NO/2020

1,563

02239141

8I1954ML4

MR/2021

1,489

Exact brand

Extra Strength Head Cold and Sinus

24 count package

02248646

8B2924GZW

JA/2021

576

Life brand

Muscle & Back Pain Relief-8

50 count package

02242180

7J1944M54

SE/2020

3,864

Life brand

Extra Strength Muscle & Back Pain Relief

40 count package

02239141

8E2054HLA

NO/2020

7,146

Pharmasave brand

Extra Strength Acetaminophen Tablets 500 mg

200 count package

00605778

8E3264KQS

AL/2021

1,022

 

What consumers should do

What Health Canada is doing

Health Canada is monitoring the company's recall. Should additional safety concerns be identified related to this issue, Health Canada will take appropriate action and inform Canadians as necessary.

Stay connected with Health Canada and receive the latest advisories and product recalls.

Également disponible en français

 

Care+ brand Extra Strength Muscle & Back Pain Relief (inner label and torn outer label) (CNW Group/Health Canada)

Exact brand Extra Strength Head Cold and Sinus (torn outer label) (CNW Group/Health Canada)

Exact brand Extra Strength Head Cold and Sinus (inner label and torn outer label) (CNW Group/Health Canada)

Life brand Muscle & Back Pain Relief-8 (torn outer label) (CNW Group/Health Canada)

Life brand Muscle & Back Pain Relief-8 (inner label and torn outer label) (CNW Group/Health Canada)

Life brand Extra Strength Muscle & Back Pain Relief (torn outer label) (CNW Group/Health Canada)

Life brand Extra Strength Muscle & Back Pain Relief (inner label and torn outer label) (CNW Group/Health Canada)

Pharmasave brand Extra Strength Acetaminophen Tablets 500 mg (torn outer label) (CNW Group/Health Canada)

SOURCE Health Canada


These press releases may also interest you

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...

at 10:35
BeiGene, Ltd. , a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company's strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets. This...

at 10:30
Invensify, Inc., Santa Clara, California, has introduced a power efficient, temperature-controlled shipping container designed to maintain stable storage temperatures for high-value pharmaceuticals before and during transport to last-mile cold chain...

at 10:30
Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. One of...



News published on and distributed by: